Cybersecurity news this week was largely grim. On the bright side, you still have one week remaining to claim up to $7,500 ...

UK’s NCSC warns prompt injection attacks may never be fully mitigated due to LLM design Unlike SQL injection, LLMs lack ...

The first release candidate of the new OWASP Top Ten reveals the biggest security risks in web development – from ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva Pharmaceuticals announced Thursday. The generic form of liraglutide (Saxenda) is ...

PARSIPPANY, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the FDA approval and U.S.

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based medical technology enterprise, was recently approved for market by China's ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to ...

As organizations lean into low-code/no-code (LCNC) platforms to streamline development and empower citizen developers, security risks become increasingly challenging to manage. One of the more ...